FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044007274> ?p ?o ?g. }

• W3044007274 endingPage "2758" @default.
• W3044007274 startingPage "2751" @default.
• W3044007274 abstract "Abstract Introduction We sought to explore the relationship between ventricular tachycardia (VT) and premature ventricular complex (PVC) burden (from implantable cardioverter‐defibrillator diagnostics), before and during corticosteroid use in patients with newly diagnosed clinically manifest cardiac sarcoidosis (CS). Methods A single‐centre, prospective cohort study was performed in consecutive patients who met all of the following criteria: (1) presentation with clinically manifest CS, (2) abnormal myocardial fluoro‐deoxyglucose (FDG) uptake on positron emission tomography scan, (3) plan for implantation with implantable cardioverter‐defibrillator device that reports accurate PVC count, (4) plan to initiate corticosteroids after the device healing period. Data were collected during each device interrogation visit for all patients in the study. For each inter‐visit period the total number of episodes of VT—sustained and nonsustained, and the number of PVCs was obtained. Each inter‐visit period was classified into one of the following three periods: (1) New diagnosis of treatment‐naive active disease without corticosteroids during the period. (2) Known treatment‐naive active disease with corticosteroids initiated during the inter‐visit period. (3) On corticosteroid therapy during the entire period. Results A total of 20 patients with a mean age of 59.7 ± 7.7 years were recruited and 82 inter‐visit periods were analyzed. All patients were corticosteroid responders based on FDG uptake. The maximum left ventricular standardized uptake value was 11.14 ± 5.19 before corticosteroid initiation and 4.07 ± 0.88 after ( p < .001). Patients with active untreated CS had an average of 496.4 ± 879.1 PVCs per day. After treatment with corticosteroids, the average PVC count increased to 1332.4 ± 1865.7/day during Period 2 ( p = .036) and to 1590.1 ± 2362.2 per day during Period 3 ( p = .008). There was also a statistically significant increase in episodes of nonsustained ventricular tachycardia (NSVT) before and after treatment with corticosteroids ( p = .017). There were too few episodes of sustained ventricular arrhythmia to analyze. Overall, 18 out of 20 patients (90%) had an increase in PVC burden after corticosteroid initiation. Conclusion This study demonstrated, on average, a threefold increase in daily PVC count in clinically manifest CS patients during treatment with corticosteroids compared to pretreatment. There was also a significant increase in episodes of NSVT. Clinicians and patients with active manifest CS should be aware that corticosteroids are unlikely to lead to a reduction in the burdens of PVC and NSVT." @default.
• W3044007274 created "2020-07-29" @default.
• W3044007274 creator A5004831482 @default.
• W3044007274 creator A5014483843 @default.
• W3044007274 creator A5034343881 @default.
• W3044007274 creator A5038013368 @default.
• W3044007274 creator A5043917469 @default.
• W3044007274 creator A5049124094 @default.
• W3044007274 creator A5050890781 @default.
• W3044007274 creator A5051748961 @default.
• W3044007274 creator A5062337728 @default.
• W3044007274 creator A5068320781 @default.
• W3044007274 creator A5073239769 @default.
• W3044007274 date "2020-08-04" @default.
• W3044007274 modified "2023-09-27" @default.
• W3044007274 title "Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: Insights from implantable cardioverter‐defibrillator diagnostics" @default.
• W3044007274 cites W1902873895 @default.
• W3044007274 cites W1965141826 @default.
• W3044007274 cites W1971199131 @default.
• W3044007274 cites W2008754612 @default.
• W3044007274 cites W2010909136 @default.
• W3044007274 cites W2011982970 @default.
• W3044007274 cites W2029742388 @default.
• W3044007274 cites W2034125744 @default.
• W3044007274 cites W2058950834 @default.
• W3044007274 cites W2060313375 @default.
• W3044007274 cites W2125618141 @default.
• W3044007274 cites W2130562407 @default.
• W3044007274 cites W2132856292 @default.
• W3044007274 cites W2487580690 @default.
• W3044007274 cites W2607280687 @default.
• W3044007274 cites W2997257053 @default.
• W3044007274 cites W4205862288 @default.
• W3044007274 doi "https://doi.org/10.1111/jce.14689" @default.
• W3044007274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32713090" @default.
• W3044007274 hasPublicationYear "2020" @default.
• W3044007274 type Work @default.
• W3044007274 sameAs 3044007274 @default.
• W3044007274 citedByCount "11" @default.
• W3044007274 countsByYear W30440072742021 @default.
• W3044007274 countsByYear W30440072742022 @default.
• W3044007274 countsByYear W30440072742023 @default.
• W3044007274 crossrefType "journal-article" @default.
• W3044007274 hasAuthorship W3044007274A5004831482 @default.
• W3044007274 hasAuthorship W3044007274A5014483843 @default.
• W3044007274 hasAuthorship W3044007274A5034343881 @default.
• W3044007274 hasAuthorship W3044007274A5038013368 @default.
• W3044007274 hasAuthorship W3044007274A5043917469 @default.
• W3044007274 hasAuthorship W3044007274A5049124094 @default.
• W3044007274 hasAuthorship W3044007274A5050890781 @default.
• W3044007274 hasAuthorship W3044007274A5051748961 @default.
• W3044007274 hasAuthorship W3044007274A5062337728 @default.
• W3044007274 hasAuthorship W3044007274A5068320781 @default.
• W3044007274 hasAuthorship W3044007274A5073239769 @default.
• W3044007274 hasConcept C126322002 @default.
• W3044007274 hasConcept C164705383 @default.
• W3044007274 hasConcept C188816634 @default.
• W3044007274 hasConcept C2776331378 @default.
• W3044007274 hasConcept C2776804153 @default.
• W3044007274 hasConcept C2777093960 @default.
• W3044007274 hasConcept C2781005686 @default.
• W3044007274 hasConcept C2781301800 @default.
• W3044007274 hasConcept C2911014034 @default.
• W3044007274 hasConcept C71924100 @default.
• W3044007274 hasConcept C72563966 @default.
• W3044007274 hasConceptScore W3044007274C126322002 @default.
• W3044007274 hasConceptScore W3044007274C164705383 @default.
• W3044007274 hasConceptScore W3044007274C188816634 @default.
• W3044007274 hasConceptScore W3044007274C2776331378 @default.
• W3044007274 hasConceptScore W3044007274C2776804153 @default.
• W3044007274 hasConceptScore W3044007274C2777093960 @default.
• W3044007274 hasConceptScore W3044007274C2781005686 @default.
• W3044007274 hasConceptScore W3044007274C2781301800 @default.
• W3044007274 hasConceptScore W3044007274C2911014034 @default.
• W3044007274 hasConceptScore W3044007274C71924100 @default.
• W3044007274 hasConceptScore W3044007274C72563966 @default.
• W3044007274 hasIssue "10" @default.
• W3044007274 hasLocation W30440072741 @default.
• W3044007274 hasOpenAccess W3044007274 @default.
• W3044007274 hasPrimaryLocation W30440072741 @default.
• W3044007274 hasRelatedWork W1534090624 @default.
• W3044007274 hasRelatedWork W2030004221 @default.
• W3044007274 hasRelatedWork W2045718995 @default.
• W3044007274 hasRelatedWork W2069600595 @default.
• W3044007274 hasRelatedWork W2314910500 @default.
• W3044007274 hasRelatedWork W2351760901 @default.
• W3044007274 hasRelatedWork W2581104969 @default.
• W3044007274 hasRelatedWork W2718767706 @default.
• W3044007274 hasRelatedWork W2791219437 @default.
• W3044007274 hasRelatedWork W4280530690 @default.
• W3044007274 hasVolume "31" @default.
• W3044007274 isParatext "false" @default.
• W3044007274 isRetracted "false" @default.
• W3044007274 magId "3044007274" @default.
• W3044007274 workType "article" @default.